Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial-Reference-Cited by-同舟云学术

Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial

Published:2006-01 Issue:1 Volume:5 Page:38-45
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Maas Andrew IR,Murray Gordon,Henney Herbert,Kassem Nadim,Legrand Valerie,Mangelus Miriam,Muizelaar Jan-Paul,Stocchetti Nino,Knoller Nachshon

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference33 articles.

1. Traumatic brain injury;Ghajar;Lancet,2000

2. Epidemiology and economics of head injury;Thurman,2001

3. The epidemiology of traumatic brain injury: a review;Bruns;Epilepsia,2003

4. Why have recent trials of neuroprotective agents in head injury failed to show convincing efficacy? A pragmatic analysis and theoretical considerations;Maas;Neurosurgery,1999

5. Nonpsychotrophic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker;Feigenbaum;Proc Natl Acad Sci USA,1989

Cited by 232 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phytocannabinoids—Evaluation of their therapeutic role in neuroinflammation;Exploration of Neuroprotective Therapy;2024-08-22

2. Restoring consciousness with pharmacologic therapy: Mechanisms, targets, and future directions;Neurotherapeutics;2024-07

3. From spreading depolarization to blood–brain barrier dysfunction: navigating traumatic brain injury for novel diagnosis and therapy;Nature Reviews Neurology;2024-06-17

4. Neuroprotective and neuroregenerative drugs after severe traumatic brain injury;Wiener klinische Wochenschrift;2024-05-15

5. Traumatic Brain Injury Outcomes After Recreational Cannabis Use;Neuropsychiatric Disease and Treatment;2024-04